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Abstract The complete amino acid sequence of protease inhibi-
tor BWI-I from buckwheat (Fagopyrum esculentum Moench) 
seeds has been established by automatic Edman degradation and 
mass spectrometry. The molecule of the inhibitor consists of 69 
amino acid residues, with a molecular mass calculated as 7743.8 
Da. The active site of the inhibitor containes an Arg45 - Asp46 bond. 
Analysis of the amino acid sequence suggests that the buckwheat 
seed protease inhibitor is a member of the proteinase inhibitor I 
family. 
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1. Introduction 
Protein protease inhibitors are widely distributed in living 
organisms. The modern classification of these proteins based 
on their amino acid sequences, active site structures and mech-
anisms of action involves at least 10 different families [1]. Plant 
protease inhibitors are classified into three main groups, 
namely Kunitz, Bowman-Birk and proteinase inhibitor I fami-
lies. The physiological role of these inhibitors in plants has not 
been established conclusively and is likely to consist of (I) 
protection from proteolytic enzymes of various pathogens and 
insects, (2) regulation of the activity of endogenous proteases, 
(3) contributing to the pool of storage proteins [2]. We have 
previously purified and characterized a number of trypsin and 
chymotrypsin inhibitors from buckwheat seeds [3-6] and dem-
onstrated that one was involved in regulation of endogenous 
metalloproteinase activity [5] while others suppressed the 
growth and development of pathogenic fungi [6]. Trypsin inhib-
itors from buckwheat seeds were also isolated and described in 
the works of other groups [7-9]. However, they did not study 
the physiological role of these proteins or their amino acid 
sequences. In the present paper we describe the complete amino 
acid sequence of the BWI-I trypsin inhibitor from buckwheat 
seeds. 
2. Experimental 
2 1. Plant material 
Dry seeds of buckwheat (Fagopyrum esclilentlim Moench) cv. Shatt-
lovskaya-5 were used 
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Abbreviations HPLC, high-performance liqUId chromatography; PE, 
pyndylethyl; PTH, phenylthiohydantoin; TFA, tnfluoroacetlc aCid. 
22 Isolation of the mhlbitor 
The inhibitor was isolated by two independent techmques. In the first 
case the seed extract was subjected to affinity chromatography on a 
trypsm-Sepharose column as described previously [6]. The fraction 
containing the total preparatIOn of buckwheat seed trypsm mhibitors 
was further chroma to graphed on a Mono Q HR 5/5 (Pharmacia, Swe-
den) column by FPLC. The sample (10 mg protem) was apphed to the 
column in 20 mM K, Na-phosphate, pH 6.8. The column was then 
washed with the same buffer and the protein was eluted with a linear 
NaCI gradient (0-100 mM, ml'min- 1, 25 min). The preparatIOn of the 
BWI-I inhibitor was finally purified by reversed-phase HPLC on an 
Aquapore RP-300 (4.6 x 100 mm) (Applied Biosystems, Inc., USA) 
column usmg an acetonitryl gradient at a flow rate of 0.5 ml'min- 1 
SolutIOn A: 0.1 % (v/v) TFA; solutIOn B: acetonitrile containing 0,08% 
(v/v) TFA. 
In the second procedure the mhibitor preparatIOn was isolated by 
fractIOnation of the seed extract on a Sephadex G-75 column [4] fol-
lowed by chromatography on the Mono Q column and reversed-phase 
HPLC as described above. 
2,3. A.lsay of the activity of the in/ubllors 
A preparatIOn of the inhibitors in 100 mM K, Na-phosphate, pH 6.8 
(1-10 ,ul) was added to 5 ,ul of a trypsin solution (I mg'ml- 1) and the 
mixture was incubated at room temperature for 10 mm. The esidual 
trypsm activity was assayed according to Erlanger et al. [10] WIth a 0.2 
mM solution of N-benzoyl-D,L-argmme-p-mtroamhde in 500 mM K, 
Na-phosphate, pH 7.5, as a substrate. One umt of the inhibitor actiVity 
produced a decrease 111 absorptIOn of 0.1 umt of trypsin actIVIty assay. 
2.4 ReductIOn and alkylatIOn of the protein 
0.5 mg of the inhibitor preparatIOn were reduced and alkylated by 
4-vinilpyridin as descnbed by Thomsen and Bayne [II]. The alkylated 
protein was dlssoluted by reversed-phase HPLC and evaporated in 
Speedvac (Savant, USA) 
25 DIgestIOn oj the protell1 hy V8 protease 
300 ,ug of reduced and alkylated protein in 100,u1 of 100 mM 
NH.HCO" pH 7.8, were digested by 2,ug of the Staphylococcus aureliS 
V8 protease (Sigma, USA) for 16 h at 3rc. The obtained peptides were 
separated by reversed-phase HPLC and evaporated m Speedvac (San-
vant, USA) 
2.6 Ammo aCid ana(rsls 
The amino aCid analYSIS of the intact BWI-I was carried out accord-
ing to a standard procedure with a Hitachi 835 amino aCid analyzer. 
Cysteine was determined as cysteic acid after OXidation of the protein 
With a mixture of H20 2 and 88% performic aCid (1:9, v/v) followed by 
hydrolYSIS With 5.7 M He!. Tryptophan was determined after hydroly-
sis of the protem with 4 M methanesulfomc aCid contaming 0.2% 
tryptamme, 
2 7. Sequence analysis 
The amino aCid sequence of the protem was determined usmg a 
model 816 protein/peptide Sequencer (Knauer GmbH, Germany) 
eqUipped With a model 120A PTH-analyzer (Applied Biosystems, Inc., 
USA) 
28. Mass spectrometry 
The mass spectra were recorded In a 252Cf plasma desorptIOn time-of-
flight spectrometer ("Electron', Sumy, Ukrame). Peptides 200·-500 pmol 
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were dIssolved In tl.1 % TFA and applied to mtrocellulose covered 
targets Th.~ C -terminal peptIde sequences were determined by electros-
pray mas,-spectrometry (ESMS) as described by Tsugita et al. [12]. 
3. Results and discussion 
The inhibitor Isolated by the second procedure (gel-filtration. 
ion-exchange chromatography on Mono Q. reversed-phase 
HPLC) was intact as demonstrated by the fact that its molecu-
lar mass after reduction and alkylation was in good agreement 
with the calculated value (Fig. 1. II) and from the results of 
N-terminal sequencing. However. the inhibitor preparation ob-
tained by the first procedure (affinity chromatography. Mono 
Q chromatography. reversed-phase HPLC) was cleaved on the 
carboxyl side of Arg45 in the active site into two fragments 
connected by a single disulfide bond (Fig. I. II). Such cleavage 
often occurs at acid pH by limited proteolysis with trypsin [13]. 
In the present case it was demonstrated by the results of N-
terminal sequence analysis and mass-spectrometry. which re-
vealed three fragments. The molecular mass of the first frag-
ment (7763.9 Oa) coincided with that calculated from the se-
quence analysis data. The two other fragments. N-terminal 
(NT) (M r 4959.6 Oa) and C-terminal (CT) (M f 2804.6 Oa). were 
formed as a result of cleavage of the S-S bond after bombard-
ment of the protein with fission products of 252Cf. N-terminal 
analysis of the inhibitor preparation showed the presence of 
two protem sequences corresponding to NT and CT fragments 
(Fig. I. II). Reduction and alkylation of the protein preparation 
resulted m two fragments. which were separated by reversed-
phase HPLC (data not shown) and sequenced. 
Amino acid analysis of the intact BWI-I revealed the pres-
ence of two half-cysteine residues, that IS typical for a certain 
group of seed protease inhibitors and the absence of histidine 
and tyrosine (Table 1). 
The strategy for determination of the amino acid sequence 
of the mhibitor is presented in Fig. 2. This sequence was deter-
I. (a) 
(b) 
II. (C) 
(d) 
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69 
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Mr 
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Mr Mr 
meas. d~fference 
7743.8 7746.2 +2.4 
7956.1 7959.3 +3.2 
7761.8 7763.9 +2.1 
(fr.1-45) 4959.6 4959.6 
4" 69 (fr.46-69) 2804.2 2804.2 
Reduction and 
alkylation 
45 
----;I,----------il 
S-PE 
4b 69 
----;I-------il 
S-PE 
5065.8 5068.6 +2.8 
2910.4 2911.6 +1.2 
Fig. 1. Structure of the protease inhIbItor from buckwheat seeds ISO-
lated by gel-filtratIOn and etc. (I) and by affinity chromatography and 
etc (II). a, c, non-reduced and non-alkylated protem: b, d, reduced and 
alkylated protem M,calc., calculated molecular mass, M,meas , meas-
ured molecular mass. 
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FIg. 2 Sequencing of the protease mhibltor from buckwheat seeds. 
PeptIdes NT and CT were obtained after protem IsolatIon by affinity 
chromatography and etc .. followed by Its reductIOn and alkylatIOn and 
separation by reversed-phase HPLC and peptIdes SP6 and SP7 were 
obtamed by dIgestion of the mtact protem, Isolated by gel-filtration and 
etc., WIth V8 protease 
mined both by sequencing from the N-terminus of the reduced 
and alkylated intact protein and by sequencing of the NT and 
CT fragments formed during purification of the inhibitor by 
affinity chromatography on trypsin-Sepharose. The sequence 
of the NT fragment (45 residues) was determined completely 
(Fig. 2). In the CT fragment the sequence of21 out of24 amino 
acid residues was established. 
To prove that the peptide bond in the inhibitor molecule was 
cleaved only at the C-terminus of Arg45 during purification by 
affinity chromatography, the intact protein, obtamed without 
affinity chromatography on trypsin-Sepharose, was digested by 
the V8 endoprotease. As a result a number of peptides were 
obtained (data not shown). one of which. SP6, contained an 
amino acid sequence (GJlo-Asp"') overlapping with the C-
terminal part of the NT-fragment and the N-terminal part of 
CT fragment. These data showed that the peptide bond be-
tween Arg45 and ASp46 is cleaved in the inhibitor obtained by 
affinity purification on trypsin-Sepharose. 
Another peptide, SP7. obtained after V8 protease digestion 
of the intact mhibitor contained the C-terminal part of the 
Table I 
Ammo aCId compo,ition of mtact buckwheat seed protease BWI-I 
mhlbitor 
Ammo aCId BWI-I 
Asp 6.7 (5) 
Asn (2) 
Thr 1.2 (l) 
Ser 26(3) 
Glu II X (8) 
Gin (2) 
Pro 4.1 (4) 
Gly 5.2 (5) 
Ala 4 1(4) 
112 Cys 20(2) 
Val lU(12) 
Met 08 (l) 
lie I. 9 (3) 
Leu 3.9 (4) 
Tyr 0.0 (0) 
Phe 1.1 (1) 
Lys 3.2 (3) 
H" 0.0 (0) 
Arg 7 I (7) 
Trp 1.5 (2) 
Total (69) 
Numbers In parenthe,,, are the reSIdues determmed after sequence 
analYSIS. 
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Fig. 3. Companson of ammo acid sequences of some members of the 
proteinase mhlbitor I family. ATSI, inhibitor from Amaranthlls callda-
illS [14], ITH5, trypsin inhibitor from pumpkin [15], BGIA, mhlbitor 
from bitter gourd [16]. Identical amino acids in the sequences are boxed. 
The arrow indicates the PI amino acid residue at the reactive sites of 
the mhlbltors. 
sequence (Arg59_Met69). In this peptide only the sequence of the 
last three C-terminal amino acids was not determined. To es-
tablish this sequence peptide SP7 was subjected to mass analy-
sis by ESMS. As a result the C-terminal sequence of SP7 was 
determined: VaI67_VaI68_Met69. The complete amino acid se-
quence of the studied inhibitor is shown in Fig. 2. The Mr of 
the protein (7746.2 Da) determined by mass-spectrometry is in 
good coincidence with the calculated value (7743.8 Da). 
Analysis of the amino acid sequence of the studied buck-
wheat seed protease inhibitor revealed a 65%, 50% and 49% 
identity with the trypsin/subtilisin inhibitor from Amaranthus 
caudatus [14], the trypsin inhibitor from pumpkin (eucurblta 
maxima) [IS] and inhibitor of the Streptomyces griseus Glu-
protease from bitter gourd (Momordica charantia) [16], respec-
tively (Fig. 3). These data suggest that BWI-I belongs to the 
proteinase inhibitor I family. The reactive site of BWI-I is 
M. A Belo::ersky et al / FEBS Letters 371 (1995) 264-266 
proposed to be Arg45_Asp46 (Fig. 3) on the basi~ of its sequence 
homology to inhibitors of this family. It should be noted that 
Arg had not been found before at the PI position at the active 
sites of inhibitors which belong to proteinase inhibitor I family. 
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